| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 02/16/2005 | CN1580264A High soluble expressed tricholsanthin mutant and its preparing method |
| 02/16/2005 | CN1579521A Traditional Chinese medicine for eliminating breast arthro myodynia |
| 02/16/2005 | CN1579515A Medicine for treating hysteromyoma and its preparation method |
| 02/16/2005 | CN1579511A Ready made traditional Chinese medicine for treating hyperplasia of mammary glans |
| 02/16/2005 | CN1579508A Chanfuxin effervescent tablets and preparation method thereof |
| 02/16/2005 | CN1579506A Effervescent tablets for treating cervicitis and preparation method |
| 02/16/2005 | CN1579504A Effervescent tablets |
| 02/16/2005 | CN1579490A Traditional Chinese medicinal preparation for women's menalgia |
| 02/16/2005 | CN1579476A Precription of traditional Chinese medicine for treating gynaecological disease, its use and preparation method |
| 02/16/2005 | CN1579472A Fangshikang external medicine preparation method |
| 02/16/2005 | CN1579452A Plant essence oil for improving male impotence |
| 02/16/2005 | CN1579451A South Radix-Isatidis soft capsule and preparation method |
| 02/16/2005 | CN1579432A Compound traditional Chinese medicine for treating fibroid and muller-iosis and its preparation method |
| 02/16/2005 | CN1579392A New generation viagra preparation for treating ED and female undersexed |
| 02/16/2005 | CN1579391A Chewing gum containing phentolamine mesylate |
| 02/16/2005 | CN1579390A Extenal preparation of phentolamine mesylate |
| 02/16/2005 | CN1579382A New decanoy-acetaldehyde sodium infusion and its preparation process |
| 02/16/2005 | CN1579381A Decanoy-acetaldehyde sodium for injection and its preparation process |
| 02/16/2005 | CN1579368A Long-service-life chinese medicine preparation for bodily diminishing inflammation and pain-relieving |
| 02/16/2005 | CN1189479C Use of leptin in inhibition of endothelial cell proliferation |
| 02/16/2005 | CN1189477C Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition |
| 02/16/2005 | CN1189211C Therapeutic methods and compsns. for treatment of in paired interpersonal and behavioral disorders |
| 02/16/2005 | CN1189168C Use of (-)-(3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance type 2-diabetes, hyperlipidemia and hyperuricemia |
| 02/15/2005 | US6855826 1,3-butadienes, perhydrobutadienes, ethylenes and ethanes as amino acid derivatives; hypotensive agents; antidiabetic agents and (pre)eclampsia treatments |
| 02/15/2005 | US6855806 Comprises secreted polypeptide for diagnosis and treatment of tumors, nervous system, reproductive and muscular disorder |
| 02/15/2005 | US6855703 Triene steroids administered to mammals for prophylaxis of diseases and disorders such as cancer, menopause or osteoporosis |
| 02/15/2005 | US6855689 Anticancer agents |
| 02/15/2005 | US6855520 Cell volume-regulated human kinase h-sgk |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
| 02/15/2005 | US6855310 Aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of acetaminophen, orphenadrine or tramadol. |
| 02/15/2005 | CA2323720C New substances derived from aza-indolic polycyclics, processes for preparing them and pharmaceutical compounds containing them |
| 02/15/2005 | CA2124339C Novel 19-nor steroids having a thiocarbon-containing chain in the 11 beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositionscontaining said steroids |
| 02/10/2005 | WO2005012282A1 Novel 2-thiosubstituted benzothiophene derivatives, method for production of and pharmaceutical compositions comprising the same |
| 02/10/2005 | WO2005011726A1 Use of follicle stimulating hormone for reduction of spermatozoa chromosomal aberration in males |
| 02/10/2005 | WO2005011705A1 Enhancement of erectile function |
| 02/10/2005 | US20050032895 Medicament for the treatment of viral skin and tumour diseases |
| 02/10/2005 | US20050032851 E. g.,N-[[4-[2-(5-Methylpyridin-3-yl)-4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl]sulfonyl]acetamide; side effect reduction; non-steroidal antiinflammatory agents; antiarthritic agents; analgesics; antipyretics; acylation of the corresponding sulfoamide by an anhydride a solvent and base |
| 02/10/2005 | US20050032820 Novel spiro compounds |
| 02/10/2005 | US20050032816 N-oxide anthranylamide derivatives and their use as medicaments |
| 02/10/2005 | US20050032809 5-HT receptor ligands and uses thereof |
| 02/10/2005 | US20050032808 Pyrazine carboxamide compounds for use in treatment of obesity, psychiatric and neurological disorders; for example, N-(1-piperidinyl)-5,6-diphenyl-2-pyrazinecarboxamide |
| 02/10/2005 | US20050032777 benzyl carbamates and ureas such as 5-(4-(4-cyclopropylmethylpiperazine-1-carbonylaminomethyl)-3-methylbenzoyl)-1-methyl-4,10-dihydropyrazolo[5,4-b][1,5]benzodiazepine, used for treatment of sexual disorders |
| 02/10/2005 | US20050032755 Dosage regimen and pharmaceutical composition for emergency contraception |
| 02/10/2005 | US20050032746 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 02/10/2005 | US20050032724 Multidrug Resistance Protein 1 (MRP1); mutagenesis |
| 02/10/2005 | US20050032680 Method of treatment of vulval vestibulitis |
| 02/10/2005 | US20050032214 Cell-specific expression/replication vector |
| 02/10/2005 | US20050032168 17 human secreted proteins |
| 02/09/2005 | EP1505150A1 Novel proteins and dnas thereof |
| 02/09/2005 | EP1504007A1 Imidazo-triazine derivatives as ligands for gaba receptors |
| 02/09/2005 | EP1503989A1 Dopamine receptor modulators as antipsychotic agents |
| 02/09/2005 | EP1503794A1 Methods of treatement using ctla-4 antibodies |
| 02/09/2005 | EP1503779A2 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 02/09/2005 | EP1503775A1 Formulations useful in the treatment of male and female impotence |
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | EP1436252A4 Hydroxyfattysulfonic acid analogs |
| 02/09/2005 | EP1401446B1 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen |
| 02/09/2005 | EP1339717B1 Novel carbamate-substituted pyrazolopyridine derivatives |
| 02/09/2005 | EP1280805B1 Novel imidazotriazinones and the use thereof |
| 02/09/2005 | EP1150960B1 Polymorphic crystalline forms of celecoxib |
| 02/09/2005 | CN1578786A Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 02/09/2005 | CN1578782A Silicon compounds |
| 02/09/2005 | CN1578779A Small organic molecule regulators of cell proliferation |
| 02/09/2005 | CN1578768A Anthranilic acid amides and pharmaceutical use thereof |
| 02/09/2005 | CN1578676A Lox concentration of peroxide for treating or preventing vaginal infections |
| 02/09/2005 | CN1578675A Extended, controlled-release pharmaceutical compositions using charged polymers |
| 02/09/2005 | CN1578670A Use of lactalapoprotein in prevention and treatment of microbial or virus infection |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1188416C Oxathiepino [6,5-b]dihydropyridines,and related compositions and preparation methods |
| 02/09/2005 | CN1188415C Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5)for treatment of sexual dysfunction |
| 02/09/2005 | CN1188412C Process for preparing crystalline form 1 of cabergoline |
| 02/09/2005 | CN1188410C Nonsteroid IL-5 inhibitor, its preparation method and medical composition containing the same inhibitor |
| 02/09/2005 | CN1188405C New Morpholinobenzamide salts |
| 02/09/2005 | CN1188189C Transdermal patch substrate containing 17-deacetyl norgestimate and use of substrate |
| 02/09/2005 | CN1188160C Medicine composition with lactogenic function and its prepn |
| 02/09/2005 | CN1188157C Chinese herbal medicine tumor-eliminating drop |
| 02/09/2005 | CN1188138C Use of refind fur-seal oil in medicine for preventing and treating climacteric metancholia and menalgia |
| 02/09/2005 | CN1188128C Triazineone compounds for treating diseases due to sarcosystis neospora and toxoplasma |
| 02/09/2005 | CN1188111C Dry powder compositions having improved dispersivity |
| 02/08/2005 | US6852749 Pyrazolidinol compounds |
| 02/08/2005 | US6852738 Potent ligands for PPAR gamma and generally have antagonist or partial agonist activity. The compoundsare for treatment, control or prevention of obesity, non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, |
| 02/08/2005 | US6852736 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 02/08/2005 | US6852726 Such as 1-(4,5-dihydro-1H-imidazol-2-ylmethyl)-3-methanesulfonyl-2-methyl-1H-indole for preventing/treating disorders modulated by alpha-1A/L adrenoceptors such as urinary incontinence and sexual disorders |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/08/2005 | US6852720 Thiazol-2-yl-imine compounds as PDE-7 inhibitors |
| 02/08/2005 | US6852698 Free radical scavengers or promoters thereof as therapeutic adjuvants in preterm parturition |
| 02/08/2005 | US6852323 Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder |
| 02/08/2005 | CA2322900C 2-(hetero)aryl-substituted purin-6-ones as phosphodiesterase inhibitors |
| 02/08/2005 | CA2184183C Inhibin compositions and methods of use thereof |
| 02/03/2005 | WO2005010189A1 OLIGONUCLEOTIDE INHIBITING THE EXPRESSION OF StAR-BINDING PROTEIN (SBP) GENE AND METHOD THEREFOR |
| 02/03/2005 | WO2005009480A2 Implants containing codrugs |
| 02/03/2005 | WO2005009436A1 Dispersible formulation of an anti-inflammatory agent |
| 02/03/2005 | WO2003101461A8 Norethindrone sustained release formulations and methods associated therewith |
| 02/03/2005 | WO2003062390A3 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling |
| 02/03/2005 | US20050027125 Intensifiers of adenosine receptors for cardiac arrhythmia |
| 02/03/2005 | US20050027103 Matrix protein for use diagnosis, treatment, and prevention of viral infections, cell proliferative and neurological disorders |
| 02/03/2005 | US20050027015 Feed containing cysteamine or a salt thereof and a stabilizer such as cyclodextrin; increased milk production in cows |
| 02/03/2005 | US20050026985 Such as N-{5-[1-(4-tert-butylphenyl)-3-pyridin-2-yl-1H-pyrazol-5-yl]pentanoyl}tyrosinamide; useful for the treatment of mammalian infertility |
| 02/03/2005 | US20050026973 New heterocyclic oxime compounds |
| 02/03/2005 | US20050026941 preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase used for prophylaxis of erectile dysfunction and cardiovascular disorders |